Bright Minds Biosciences Inc. (CSE:DRUG)
Canada flag Canada · Delayed Price · Currency is CAD
106.49
+6.49 (6.49%)
At close: Dec 5, 2025

Bright Minds Biosciences Ratios and Metrics

Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2019
Market Capitalization
8297828107-
Upgrade
Market Cap Growth
11156.87%-19.09%-71.17%-73.71%--
Upgrade
Enterprise Value
778001985-
Upgrade
Last Close Price
106.491.472.158.5045.20-
Upgrade
PB Ratio
16.001.191.232.675.51-
Upgrade
P/TBV Ratio
16.001.191.232.675.52-
Upgrade
Debt / Equity Ratio
0.000.020.010.01--
Upgrade
Quick Ratio
85.3910.9224.168.0031.125.30
Upgrade
Current Ratio
86.5611.3224.268.1131.385.82
Upgrade
Return on Equity (ROE)
-30.79%-46.18%-86.02%-99.95%-85.94%-124.04%
Upgrade
Return on Assets (ROA)
-18.31%-25.19%-47.45%-57.32%-51.52%-61.70%
Upgrade
Return on Capital (ROIC)
-18.53%-26.53%-51.86%-61.21%-53.54%-76.64%
Upgrade
Return on Capital Employed (ROCE)
-16.60%-46.90%-109.10%-138.80%-44.40%-65.10%
Upgrade
Earnings Yield
-1.08%-42.70%-90.90%-53.20%-8.09%-
Upgrade
Buyback Yield / Dilution
-49.67%-15.87%-50.58%-37.64%-148.42%-74.24%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.